Posted On: 07/06/2014 10:43:14 AM
Post# of 30035
Newest Fibonacci post on twitter:
fibonacci @fibonacci1170 Jan 25
The Boston University Center for the Study of Traumatic Encephalopathy (BU CSTE) will use $AMBS #LymPro biomarker to screen CTE patients.
fibonacci @fibonacci1170 May 9
$AMBS alert: BU CSTE has found #LymPro biomarker accurately detects CTE+TBI symptoms in blood. Data in July. Massive AMBS inflection point.
fibonacci @fibonacci1170 28m
From info I am getting, $AMBS's #LymPro to overtake AZD4694, Amyvid, Vizamyl. Could be licensed to a major pharma 2014, w/ 2016 FDA approval
fibonacci @fibonacci1170 Jan 25
The Boston University Center for the Study of Traumatic Encephalopathy (BU CSTE) will use $AMBS #LymPro biomarker to screen CTE patients.
fibonacci @fibonacci1170 May 9
$AMBS alert: BU CSTE has found #LymPro biomarker accurately detects CTE+TBI symptoms in blood. Data in July. Massive AMBS inflection point.
fibonacci @fibonacci1170 28m
From info I am getting, $AMBS's #LymPro to overtake AZD4694, Amyvid, Vizamyl. Could be licensed to a major pharma 2014, w/ 2016 FDA approval
(0)
(0)Scroll down for more posts ▼
